TriNetX Stock

trinetx.comHealthcareFounded: 1900Funding to Date: $94.31MM

TriNetX is the developer of a health research network designed to optimize clinical research and enable discoveries through the creation of real-world evidence.

Register for Details

For more details on financing and valuation for TriNetX, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for TriNetX.

Register Today

Team

Management Team

David Fusari
Co-Chief Technology Officer & Vice President
Brian Flaherty
Chief Commercial Officer
Gadi Lachman
Chief Executive Officer & Board Member
Steve Kundrot
Co-Chief Technology Officer
Manfred Stapff Ph.D
Chief Medical Officer & Senior Vice President

Board Members

Leslie Henshaw
Deerfield Management
Morana Jovan-Embiricos Ph.D
Bard Geesaman Ph.D
MPM Capital
Jeff Margolis
Gadi Lachman
Tony Rosenberg
MPM Capital

Other companies like TriNetX in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B

News

/PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world...
The market for technology and services for clinical drug trials is expected to reach $68.9 billion over the next seven years. The trials, which are necessary to bring new healthcare treatments to market, are by necessity prolonged, complicated affairs. Several companies are vying for a piece of thi…